Tern plc CEO Al Sisto says “…very exciting times for Wyld Networks”

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Wyld Networks AB has announced an equity fundraising of approximately SEK 7.3 million (approximately £0.58 million), before transaction costs. Wyld Networks’ shares are traded on the Nasdaq First North Growth Market in Stockholm and the Fundraise price of 12.03 SEK per Wyld Networks share is at a 12.5% discount to the five-day volume weighted average price of Wyld Networks’ shares from 31 October to 4 November 2022.

Wyld Networks has undertaken the Fundraise with certain strategic and long-term investors to provide the business with additional capital to further expand its operations in order to meet the growing demand and to accelerate its growth.  Wyld Networks intends to use the proceeds from the Fundraise to strengthen its commercial team in order to accelerate the conversion of launch partners into paying customers and to invest in its development team to maintain competitive advantage and execute on its product roadmap. Neither Tern nor any of its directors have participated in the Fundraise.

Following the Fundraise, Tern’s holding in Wyld Networks’ equity of 5,171,425 Wyld Networks shares will reduce from 49.2% to approximately 46.5%.

Commenting Al Sisto, CEO of Tern plc, said: “These are very exciting times for Wyld Networks as it continues to build the business ahead of the expected launch of its commercial sensor-to-satellite service in December 2022.  Tern is very supportive of Wyld Networks using their NASDAQ First North quote and the directed share issue process to access the growth capital they require, whilst enabling Tern to maintain a very significant holding as their largest shareholder.  We look forward to reporting on Wyld Networks’ further progress in due course.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Device Authority highlights security risks as AI begins controlling physical machines

Device Authority examines the security risks of AI-controlled machinery and the role of device identity, authentication and access controls...

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies....

Search